Literature DB >> 26044347

Cathelicidin-BF suppresses intestinal inflammation by inhibiting the nuclear factor-κB signaling pathway and enhancing the phagocytosis of immune cells via STAT-1 in weanling piglets.

Hongbo Yi1, Caihua Yu1, Haiwen Zhang1, Deguang Song1, Denghu Jiang1, Huahua Du1, Yizhen Wang2.   

Abstract

The severity of intestinal inflammation in mammals can be profoundly impacted by weaning stress. Cathelicidins protect intestinal homeostasis by not only directly killing bacteria but also immune regulators. Here, we investigated the effects of cathelicidin-BF (C-BF) derived from the snake venoms of Bungarus fasciatus on weaning stress and intestinal inflammation and examined the mechanisms by which C-BF modulates intestinal immune responses in weanling piglets. We found that C-BF treatment significantly increased performance and reduced the diarrheal index in weanling piglets. Serum IL-6, IL-22 and TNF-α production was decreased by C-BF treatment. We demonstrated that C-BF inhibited the expression of the inflammatory cytokines TNF-α, IL-6 and IL-8 but increased the expression of the anti-inflammatory cytokine IL-10 in the intestine. We also demonstrated that C-BF suppressed inflammation by down-regulating the nuclear factor-κB (NF-κB) signaling pathway in the intestine and in LPS-induced macrophages in vitro. However, C-BF significantly induced the phosphorylation of signal transducer and activator of transcription 1 (STAT-1) to enhance the phagocytosis of macrophages when inflammation was suppressed. In summary, our study demonstrated that C-BF suppressed intestinal inflammation by down-regulating the NF-κB signaling pathway and enhancing the phagocytosis of immune cells by activating STAT-1 during weaning.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Cathelicidin-BF; Inflammation; Nuclear factor-κB; Phagocytosis; STAT-1; Weaning stress

Mesh:

Substances:

Year:  2015        PMID: 26044347     DOI: 10.1016/j.intimp.2015.05.034

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  16 in total

1.  Antimicrobial peptide CC34 attenuates intestinal inflammation via downregulation of the NF-κB signaling pathway.

Authors:  Liqiang Dong; Huan Yang; Zhao Wang; Ning Jiang; Aizhong Zhang
Journal:  3 Biotech       Date:  2021-08-04       Impact factor: 2.893

2.  PAM, OLA, and LNA are Differentially Taken Up and Trafficked Via Different Metabolic Pathways in Porcine Adipocytes.

Authors:  Caihua Yu; Lingling Xi; Jin Chen; Qin Jiang; Hongbo Yi; Yizhen Wang; Xinxia Wang
Journal:  Lipids       Date:  2017-10-20       Impact factor: 1.880

3.  Effects of Immobilized Antimicrobial Peptides on Growth Performance, Serum Biochemical Index, Inflammatory Factors, Intestinal Morphology, and Microbial Community in Weaning Pigs.

Authors:  Nian Liu; Xiaokang Ma; Xianren Jiang
Journal:  Front Immunol       Date:  2022-03-29       Impact factor: 7.561

4.  Hydrostatin-TL1, an Anti-Inflammatory Active Peptide from the Venom Gland of Hydrophis cyanocinctus in the South China Sea.

Authors:  Ningyuan Wang; Yan Huang; An Li; Hailong Jiang; Jie Wang; Jianzhong Li; Lei Qiu; Ka Li; Yiming Lu
Journal:  Int J Mol Sci       Date:  2016-11-22       Impact factor: 5.923

5.  Protection Mechanism of Clostridium butyricum against Salmonella Enteritidis Infection in Broilers.

Authors:  Xiaonan Zhao; Jie Yang; Lili Wang; Hai Lin; Shuhong Sun
Journal:  Front Microbiol       Date:  2017-08-09       Impact factor: 5.640

Review 6.  Hitchhiking with Nature: Snake Venom Peptides to Fight Cancer and Superbugs.

Authors:  Clara Pérez-Peinado; Sira Defaus; David Andreu
Journal:  Toxins (Basel)       Date:  2020-04-15       Impact factor: 4.546

7.  Effects of the antimicrobial peptide WK3 on diarrhea, growth performance and intestinal health of weaned piglets challenged with enterotoxigenic Escherichia coli K88.

Authors:  Licong Zhang; Tao Guo; Na Zhan; Taotao Sun; Anshan Shan
Journal:  Food Nutr Res       Date:  2021-05-11       Impact factor: 3.894

8.  High therapeutic efficacy of Cathelicidin-WA against postweaning diarrhea via inhibiting inflammation and enhancing epithelial barrier in the intestine.

Authors:  Hongbo Yi; Lin Zhang; Zhenshun Gan; Haitao Xiong; Caihua Yu; Huahua Du; Yizhen Wang
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

9.  Lasso Peptide Microcin J25 Effectively Enhances Gut Barrier Function and Modulates Inflammatory Response in an Enterotoxigenic Escherichia coli-Challenged Mouse Model.

Authors:  Xiuliang Ding; Haitao Yu; Shiyan Qiao
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

10.  Anti-inflammatory and antibacterial effects of human cathelicidin active fragment KR-12 in the mouse models of colitis: a novel potential therapy of inflammatory bowel diseases.

Authors:  Natalia Fabisiak; Adam Fabisiak; Anna Chmielowiec-Korzeniowska; Leszek Tymczyna; Wojciech Kamysz; Radzisław Kordek; Marta Bauer; Elżbieta Kamysz; Jakub Fichna
Journal:  Pharmacol Rep       Date:  2020-11-21       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.